RDD Europe 2017 Interactive Workshops

RDD Europe 2017 featured a half-day of Interactive Workshop Sessions during which the following companies sponsored 60-minute presentations (including demonstrations and questions) on new technologies and services related to nasal and pulmonary drug delivery. Focused presentations were followed by a brief question and answer session. Meeting participants selected and attended up to THREE of these sessions (on the Registration Form) which were presented on Wednesday, April 26, 2017, from 2:00 to 6:00 PM at the Congress Center.

3M Drug Delivery Systems
The New Future: Introducing the Next Generation pMDI

Amcor
The Critical Role of Primary Packaging within the Qualification of Dry Powder Inhalers

Aptar Pharma & Propeller Health
Using Connected pMDIs to Monitor Inhaler Use and Drive Better Quality of Care

Capsugel
Engineered Particle Platform for Rapid Assessment of Inhaled Formulations: In-vitro and in-vivo evaluations

Centre of Postgraduate Medical Education (CMKP), Warsaw
Optimizing Dose Delivery of Nebulized Drugs

FluidDA
Functional Respiratory Imaging (FRI): Assessment of Lung Health to Optimize Respiratory Drug Delivery

H&T Presspart & Cohero Health
Smart Inhalers of the Future

Harro Höfliger Verpackungsmaschinen
Novel Inhaler for Controlled Pulmonary Delivery of Cannabis: Therapeutic and Technical Aspects

Hovione
Advanced Characterization and Design of Inhalable Powder Formulations

Phillips-Medisize
Realizing the Benefits of Connected Health in Respiratory Drug Delivery

Proveris Scientific
Using a Novel Rapid Screening Technique to Streamline pMDI Formulation and Device Development

Qualicaps
Impact of Capsule Type on the Aerodynamic Performance of Dry Powder Formulations for Inhalation

RDD Europe 2017 Interactive Workshops

RDD Europe 2017 featured a half-day of Interactive Workshop Sessions during which the following companies sponsored 60-minute presentations (including demonstrations and questions) on new technologies and services related to nasal and pulmonary drug delivery. Focused presentations were followed by a brief question and answer session. Meeting participants selected and attended up to THREE of these sessions (on the Registration Form) which were presented on Wednesday, April 26, 2017, from 2:00 to 6:00 PM at the Congress Center.

3M Drug Delivery Systems
The New Future: Introducing the Next Generation pMDI

Amcor
The Critical Role of Primary Packaging within the Qualification of Dry Powder Inhalers

Aptar Pharma & Propeller Health
Using Connected pMDIs to Monitor Inhaler Use and Drive Better Quality of Care

Capsugel
Engineered Particle Platform for Rapid Assessment of Inhaled Formulations: In-vitro and in-vivo evaluations

Centre of Postgraduate Medical Education (CMKP), Warsaw
Optimizing Dose Delivery of Nebulized Drugs

FluidDA
Functional Respiratory Imaging (FRI): Assessment of Lung Health to Optimize Respiratory Drug Delivery

H&T Presspart & Cohero Health
Smart Inhalers of the Future

Harro Höfliger Verpackungsmaschinen
Novel Inhaler for Controlled Pulmonary Delivery of Cannabis: Therapeutic and Technical Aspects

Hovione
Advanced Characterization and Design of Inhalable Powder Formulations

Phillips-Medisize
Realizing the Benefits of Connected Health in Respiratory Drug Delivery

Proveris Scientific
Using a Novel Rapid Screening Technique to Streamline pMDI Formulation and Device Development

Qualicaps
Impact of Capsule Type on the Aerodynamic Performance of Dry Powder Formulations for Inhalation

Back to Top